Abstract 559: Combination of PRMT5 and Mcl-1 inhibitors overcomes immune checkpoint inhibitor resistance in pleural mesothelioma.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Baylor College of Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148682193
Cites:
Cited by:
Related to: